← All stories
Markets
Edesa Biotech stock tumbles on public offering launch
2 outlets - including Investing and Financialpost - are covering this story. TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today ann…
Covered by 2 outlets
All coverage · 2 articles
Investing.com Stock Market
·2h ago
Edesa Biotech stock tumbles on public offering launch
Financial Post
·2h ago
Edesa Biotech Announces Proposed Public Offering
TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today ann…